Abstract
The present study highlights the apoptotic activity of magnetic Fe3O4 nanoparticulates functionalized by glutamic acid and 2-pyridinecarboxaldehyde thiosemicarbazone (PTSC) toward human lung epithelial carcinoma A549 cell line. To this aim, the Fe3O4 nanoparticulates were prepared using co-precipitation method. Then, the glutamic acid and Fe3O4 nanoparticulates were conjugated to each other. The product was further functionalized with bio-reactive PTSC moiety. In addition, the synthesized Fe3O4@Glu/PTSC nanoparticulates were characterized by physico-chemical techniques including scanning electron microscope (SEM), energy dispersive X-ray (EDX), X-ray diffraction (XRD), Fourier-transform infrared (FT–IR) spectroscopy and zeta potential analysis. The effects of in vitro cell viability in Fe3O4@Glu/PTSC nanoparticulate indicated the anti-proliferative properties in a dose-dependent manner (IC50 = 135.6 µM/mL). The high selectivity for tumor cells and far below of activity in HEK293 non-tumorigenic cells is considered as an important feature for this complex (SI, 3.48). Based on the results, PTSC failed to reveal any activity against A549 cells alone. However, Fe3O4 nanoparticulates had some effects in inhibiting the growth of lung cancer cell. Furthermore, Bax and Bcl-2 gene expressions were quantified by real-time PCR method. The expression of Bax increased 1.62-fold, while the expression of Bcl-2 decreased 0.76-fold at 135.6 µM/mL concentration of Fe3O4@Glu/PTSC compared to untreated A549 cells. Furthermore, the Fe3O4@Glu/PTSC nanoparticulate-inducing apoptosis properties were evaluated by Hoechst 33258 staining, Caspase-3 activation assay and Annexin V/propidium iodide staining. The results of the present study suggest that Fe3O4@Glu/PTSC nanoparticulates exhibit effective anti-cancer activity against lung cancer cells.
Similar content being viewed by others
References
Prabhu VV, Elangovan P, Devaraj SN, Sakthivel KM (2018) Gene 679:352–359
Sever B, Akalin Çiftci G, Özdemir A, Altintop MD (2019) J Res Pharm 23:16–24
Ganim MA, Baloglu MC, Aygun A, Altunoglu YC, Sayiner HS, Kandemirli F, Sen F (2018) Int J Biol Macromol 122:1271–1278
Altıntop MD, Atlı Ö, Ilgın S, Demirel R, Özdemir A, Kaplancıklı ZA (2016) Eur J Med Chem 108:406–414
Da Silva Mesquita R, Tadei WP, Bastos AMB (2018) Brazil J Entomol Nematol 10:37–42
Liu B, Sun R, Luo H, Liu X, Jiang M, Yuan C, Yang L, Hu J (2017) Immunobiology 222(2):198–205
Zheng JH, Follis AV, Kriwacki RW, Moldoveanu T (2016) FEBS J 283(14):2690–2700
Schirrmacher V (2019) FEBS J 283:2690–2700
Li-Weber M (2009) Cancer Treat Rev 35(1):57–68
Akladios FN, Andrew SD, Parkinson CJ (2016) JBIC J Biol Inorg Chem 21(8):931–944
Pelosi G (2010) Open Crystallogr J 3:16–28
Gou Y, Wang J, Chen S, Zhang Z, Zhang Y, Zhang W, Yang F (2016) Eur J Med Chem 123:354–364
Jansson PJ, Sharpe PC, Bernhardt PV, Richardson DR (2010) J Med Chem 53(15):5759–5769
El Metwally NM, Arafa R, El-Ayaan U (2014) Therm Anal Calorim 115(3):2357–2367
Babu KR, Muckenthaler MU (2016) J Mol Med 94(3):347–359
Whitnall M, Howard J, Ponka P, Richardson DR (2006) Proc Natl Acad Sci 103(40):14901–14906
Liu Y, Li J, Xu K, Gu J, Huang L, Zhang L, Liu N, Kong J, Xing M, Zhang L (2018) Toxicol Lett 292:151–161
Wang J, Sui M, Fan W (2010) Curr Drug Metab 11(2):129–141
Lisic EC, Rand VG, Ngo L, Kent P, Rice J, Gerlach D, Papish ET, Jiang X (2018) Open J Med Chem 8(2):30
Prakash Kinthada M, Gust R (2018) Int J Drug Des Dev 1(1):1001
Akam EA, Tomat E (2016) Bioconjug Chem 27(8):1807–1812
Kovacevic Z, Chikhani S, Lovejoy DB, Richardson DR (2011) Mol Pharmacol 80:598–609
Zhang H, Thomas R, Oupicky D, Peng F (2008) J Biol Inorg Chem 13(1):47–55
Yazdani F, Seddigh M (2016) Mater Chem Phys 184:318–323
Cree IA (2011) Cancer cell culture: methods and protocols. Springer, Berlin
Kirschner KM, Wagner N, Wagner K-D, Wellmann S, Scholz H (2006) J Biol Chem 281(42):31930–31939
Zhang B, Luo H, Xu Q, Lin L, Zhang B (2017) Oncotarget 8(8):13620
Convertini P, Tramutola F, Iacobazzi V, Lupattelli P, Chiummiento L, Infantino V (2015) Chem Biol Interact 237:1–8
Peña-Morán O, Villarreal M, Álvarez-Berber L, Meneses-Acosta A, Rodríguez-López V (2016) Molecules 21(8):1013
Cabrera M, Gomez N, Lenicov FR, Echeverría E, Shayo C, Moglioni A, Fernández N, Davio C (2015) PLoS One 10(9):e0136878
Suliman YAO, Ali D, Alarifi S, Harrath AH, Mansour L, Alwasel SH (2015) Environ Toxicol 30(2):149–160
Wang Y, Gao W, Shi X, Ding J, Liu W, He H, Wang K, Shao F (2017) Nature 547(7661):99
Zhao Y, Guo C, Wang L, Wang S, Li X, Jiang B, Wu N, Guo S, Zhang R, Liu K (2017) Biochem Biophys Res Commun 491(1):65–71
Pearce MC, Gamble JT, Kopparapu PR, O’Donnell EF, Mueller MJ, Jang HS, Greenwood JA, Satterthwait AC, Tanguay RL, Zhang X-K (2018) Oncotarget 9(40):26072
Chen B, Liang Y, Wu W, Cheng J, Xia G, Gao F, Ding J, Gao C, Shao Z, Li G (2009) Int J Nanomed 4:251
Eimani BG, Sanati MH, Houshmand M, Ataei M, Akbarian F, Shakhssalim N (2014) Cell J (Yakhteh) 15(4):356
Lopez JA, González F, Bonilla FA, Zambrano G, Gómez ME (2010) Revista Latinoamericana de Metalurgia y Materiales 30(1):60–66
Tadjarodi A, Ferdowsi SM, Zare-Dorabei R, Barzin A (2016) Ultrason Sonochem 33:118–128
Bamgboye TT, Bamgboye OA (1985) Inorg Chim Acta 105(3):223–226
Shandiz SAS, Montazeri A, Abdolhosseini M, Shahrestani SH, Hedayati M, Moradi-Shoeili Z, Salehzadeh A (2018) J Cluster Sci 29(6):1107–1114
Zargoosh K, Zilouei H, Mohammadi MR, Abedini H (2014) CLEAN Soil Air Water 42(9):1208–1215
El-Boubbou K (2018) Nanomedicine 13(8):929–952
Joseph E, Singhvi G (2019) Nanomaterials for Drug Delivery and Therapy 1:91–116
Liang W, Li X, Li Y, Li C, Gao B, Gan H, Li S, Shen J, Kang J, Ding S (2014) Int J Oncol 44(1):91–98
Lovejoy DB, Sharp DM, Seebacher N, Obeidy P, Prichard T, Stefani C, Basha MT, Sharpe PC, Jansson PJ, Kalinowski DS (2012) J Med Chem 55(16):7230–7244
Kalaivani P, Saranya S, Poornima P, Prabhakaran R, Dallemer F, Padma VV, Natarajan K (2014) Eur J Med Chem 82:584–599
Qi J, Zheng Y, Qian K, Tian L, Zhang GX, Cheng Z, Wang Y (2017) J Inorg Biochem 177:110–117
Prabhakaran R, Kalaivani P, Poornima P, Dallemer F, Huang R, Vijaya Padma V, Natarajan K (2013) Bioorg Med Chem 21(21):6742–6752
de Oliveira PF, Alves JM, Damasceno JL, Oliveira RAM, Dias Júnior H, Crotti AEM, Tavares DC (2015) Revista Brasileira de Farmacognosia 25(2):183–188
Matesanz AI, Jimenez-Faraco E, Ruiz MC, Balsa LM, Navarro-Ranninger C, León IE, Quiroga AG (2018) Inorg Chem Front 5(1):73–83
Hall MD, Brimacombe KR, Varonka MS, Pluchino KM, Monda JK, Li J, Walsh MJ, Boxer MB, Warren TH, Fales HM (2011) J Med Chem 54(16):5878–5889
Zhang G, Ding L, Renegar R, Wang X, Lu Q, Huo S, Chen YH (2011) Cancer Sci 102(6):1216–1222
Wu L, Zhang F, Wei Z, Li X, Zhao H, Lv H, Ge R, Ma H, Zhang H, Yang B (2018) Biomater Sci 6(10):2714–2725
Yuan J, Lovejoy DB, Richardson DR (2004) Blood 104(5):1450–1458
Qi J, Deng J, Qian K, Tian L, Li J, He K, Huang X, Cheng Z, Zheng Y, Wang Y (2017) Eur J Med Chem 134:34–42
Deus CM, Santos GL, Loureiro R, Vega-Naredo I, Faneca H, Oliveira PJ (2015) Curr Med Chem 22(20):2438–2457
Elmore S (2007) Toxicol Pathol 35(4):495–516
Hingorani R, Deng J, Elia J, McIntyre C, Mittar D (2011) BD Biosciences 1–11
Namvar F, Rahman HS, Mohamad R, Baharara J, Mahdavi M, Amini E, Chartrand MS, Yeap SK (2014) Int J Nanomed 9:2479–2488
Delbridge A, Strasser A (2015) Cell Death Differ 22(7):1071
Grobmyer SR, Moudgil BM (2010) Biomed Eng Online 9:55–56
Acknowledgements
We express gratefulness to the biology department, Islamic Azad University, Rasht, Iran.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors do not have any conflict of interest related to this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Habibi, A., Sadat Shandiz, S.A., salehzadeh, A. et al. Novel pyridinecarboxaldehyde thiosemicarbazone conjugated magnetite nanoparticulates (MNPs) promote apoptosis in human lung cancer A549 cells. J Biol Inorg Chem 25, 13–22 (2020). https://doi.org/10.1007/s00775-019-01728-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-019-01728-4